News headlines about Delcath Systems (NASDAQ:DCTH) have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Delcath Systems earned a news impact score of 0.14 on Accern’s scale. Accern also gave media coverage about the medical device company an impact score of 45.6019477159148 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the news headlines that may have impacted Accern’s analysis:

Delcath Systems (NASDAQ:DCTH) traded up 2.56% during trading on Friday, reaching $0.06. The company had a trading volume of 5,247,956 shares. The company has a 50-day moving average price of $0.10 and a 200 day moving average price of $0.09. The stock’s market cap is $25.46 million. Delcath Systems has a 52-week low of $0.02 and a 52-week high of $3.27.

TRADEMARK VIOLATION NOTICE: “Delcath Systems (DCTH) Receiving Somewhat Favorable Media Coverage, Accern Reports” was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at

Delcath Systems Company Profile

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Insider Buying and Selling by Quarter for Delcath Systems (NASDAQ:DCTH)

Receive News & Ratings for Delcath Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems Inc. and related companies with's FREE daily email newsletter.